About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Study of Clinical Outcomes of Thyroid Cancer | Clinical Trials | Clareo Health

Back to clinical trial search

UNKNOWNNCT04031339

Study of Clinical Outcomes of Thyroid Cancer

The Italian Thyroid Cancer Observatory (ITCO) repository was established to collect data on thyroid cancer management in a prospective and consecutive series of newly-diagnosed patients, enrolled in c...

Lead sponsor: University of Roma La Sapienza•35 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Clareo turns complex medical information into clear understanding you can use.

Bring this clarity to your next appointment.

Keep all your medical notes and next steps in one place.

Contacts

Cosimo Durante, MD,PhD

CONTACT

cosimo.durante@uniroma1.it

Giorgio Grani, MD,PhD

CONTACT

giorgio.grani@uniroma1.it

Sponsors

Lead Sponsor

University of Roma La Sapienza

Collaborators

Italian Thyroid Cancer Observatory (ITCO) Foundation
Catholic University of the Sacred Heart

Little information is available on current practices in the treatment of thyroid cancer: a web-based thyroid cancer database was created to collect real-life data. The participants' network include tertiary referral centers operating at the national level, as well as smaller hospital-based units with local or regional recruitment areas.

Age

All ages

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•pathologically confirmed thyroid cancer
•clinical follow-up including serum thyroglobulin (Tg) assays, circulating Tg antibodies, and high-resolution gray-scale and color Doppler US of the thyroid bed and cervical lymph node compartments. Additional imaging studies and/or fine-needle aspiration biopsy for cytology are ordered at the examiner's discretion in accordance with evidence-based guidelines
•entire follow-up at a participating clinical center.

Exclusion Criteria

•patients referred to the recruiting centers ≥12 months from the primary treatment

Related studies

EMDR Integrative Group Protocol and Individual Treatment for Patients With Cancer: A Pilot Study

NCT07447089 · Thyroid Neoplasms, Neoplasm, and more

TRAIL Study: Feasibility and Pilot

NCT06220656 · Thyroid Nodule, Thyroid Neoplasms, and more

Dual-Channel Near-Infrared Autofluorescence Imaging and AI Analysis to Locate Parathyroid Glands (PTFinder)

NCT07010380 · Thyroid Neoplasms, Hyperparathyroidism, and more

Study of Anlotinib Hydrochloride Capsules in the Treatment of Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma

NCT05994365 · Thyroid Neoplasms

Institut Paoli Calmettes Thyroid Cancer Database

NCT02869620 · Thyroid Neoplasms

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: May 10, 2023Terms

Trial snapshot

StatusUNKNOWN

Phase—

Enrollment15,000

Start dateJan 2013

Last updatedMay 10, 2023

Condition

Thyroid Neoplasms

Locations shown

A.S.S.T. Grande Ospedale Metropolitano Niguarda

Milan, Milano

Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico

Milan, Milano

IRCCS Ospedale San Raffaele

Milan, Milano

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: May 10, 2023Data synced to Clareo: May 10, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions